Depression in systemic lupus erythematosus: gender differences in the performance of the Beck Depression Inventory (BDI),Center for Epidemiologic Studies Depression Scale (CES-D),and Hospital Anxiety and Depression Scale (HADS)
Restricted accessResearch articleFirst published online February, 2018
Depression in systemic lupus erythematosus: gender differences in the performance of the Beck Depression Inventory (BDI),Center for Epidemiologic Studies Depression Scale (CES-D),and Hospital Anxiety and Depression Scale (HADS)
The prevalence of depressive symptoms in patients with systemic lupus erythematosus (SLE) varies widely between different cohorts (17–75%), primarily due to factors such as the heterogeneity of the samples and the instruments used to detect depressive symptoms. Most of these instruments are self-administered questionnaires that have different characteristics and approaches to depressive symptoms. This study aimed to evaluate gender differences in the performance of three questionnaires used to assess depressive symptoms in patients with SLE: the Beck Depression Inventory (BDI), Center for Epidemiologic Studies Depression Scale (CES-D), and Hospital Anxiety and Depression Scale (HADS). This study included 54 male and 54 female SLE patients. Depressive symptoms were assessed using BDI (cutoffs 13 and 15), CES-D and HADS. The gold standard method used was the diagnostic criteria of the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders. Regarding the performance of the BDI questionnaire, no significant differences in sensitivity or specificity were found between the genders. The specificity of the CES-D questionnaire was significantly greater for the male group (83% vs. 62.5%, p = 0.0309), and its sensitivity was non-significantly higher for the female group (92.9% for women and 71.4% for men; p = 0.2474). Regarding the performance of the HADS, we found similar sensitivities between the genders (71.4%) but a higher specificity among the men (95.7% in men and 82.5% in women, p = 0.0741). In conclusion, our results suggest the presence of gender differences in the performance of the questionnaires in SLE patients. The BDI had the most similar performances between the male and female groups. In contrast, the CES-D and HADS-D showed considerable variation in performances between men and women with SLE.
PalaginiLMoscaMTaniCGemignaniAMauriMBombardieriS. Depression and systemic lupus erythematosus: A systematic review. Lupus2013; 22: 409–416.
6.
LisitsynaTAVel’tishchevDSeravinaOFet al.Prevalence of mental disorders in SLE patients: Correlations with the disease activity and comorbid chronic conditions. Ter Arkh2009; 81: 10–16.
7.
MokCC. Epidemiology and survival of systemic lupus erythematosus in Hong Kong Chinese. Lupus2011; 20: 767–771.
8.
GrecoCMLiTSattarAet al.Association between depression and vascular disease in systemic lupus erythematosus. The Journal of rheumatology2012; 39: 262–268.
9.
XieLFChenPLPanHFet al.Prevalence and correlates of suicidal ideation in SLE inpatients: Chinese experience. Rheumatol Int2012; 32: 2707–2714.
10.
ZakeriZShakibaMNarouieBMladkovaNGhasemi-RadMKhosraviA. Prevalence of depression and depressive symptoms in patients with systemic lupus erythematosus: Iranian experience. Rheumatol Int2012; 32: 1179–1187.
11.
MoldovanICoorayDCarrFet al.Pain and depression predict self-reported fatigue/energy in lupus. Lupus2013; 22: 684–689.
12.
ChoiSTKangJIParkIHet al.Subscale analysis of quality of life in patients with systemic lupus erythematosus: Association with depression, fatigue, disease activity and damage. Clin Exp Rheumatol2012; 30: 665–672.
13.
PetterssonSLovgrenMErikssonLEet al.An exploration of patient-reported symptoms in systemic lupus erythematosus and the relationship to health-related quality of life. Scand J Rheumatol2012; 41: 383–390.
14.
MakATangCSHoRC. Serum tumour necrosis factor-alpha is associated with poor health-related quality of life and depressive symptoms in patients with systemic lupus erythematosus. Lupus2013; 22: 254–261.
15.
ShenBTanWFengGet al.The correlations of disease activity, socioeconomic status, quality of life, and depression/anxiety in Chinese patients with systemic lupus erythematosus. Clin Dev Immunol2013; 2013: 270878–270878.
16.
Yilmaz-OnerSOnerCDogukanFMet al.Anxiety and depression predict quality of life in Turkish patients with systemic lupus erythematosus. Clin Exp Rheumatol2015; 33: 360–365.
17.
PetriMNaqibuddinMCarsonKAet al.Depression and cognitive impairment in newly diagnosed systemic lupus erythematosus. J Rheumatol2010; 37: 2032–2038.
18.
CavacoSMartins da SilvaASantosEet al.Are cognitive and olfactory dysfunctions in neuropsychiatric lupus erythematosus dependent on anxiety or depression?J Rheumatol2012; 39: 770–776.
19.
SibbittWLJrBrandtJRJohnsonCRet al.The incidence and prevalence of neuropsychiatric syndromes in pediatric onset systemic lupus erythematosus. J Rheumatol2002; 29: 1536–1542.
20.
ManeetonBManeetonNLouthrenooW. Prevalence and predictors of depression in patients with systemic lupus erythematosus: A cross-sectional study. Neuropsychiatr Dis Treat2013; 9: 799–804.
21.
NeryFGBorbaEFVianaVSet al.Prevalence of depressive and anxiety disorders in systemic lupus erythematosus and their association with anti-ribosomal P antibodies. Progr Neuropsychopharmacol Biol Psychiatry2008; 32: 695–700.
22.
BachenEAChesneyMACriswellLA. Prevalence of mood and anxiety disorders in women with systemic lupus erythematosus. Arthritis Rheum2009; 61: 822–829.
23.
LimLRonMAOrmerodIEet al.Psychiatric and neurological manifestations in systemic lupus erythematosus. Q J Med1988; 66: 27–38.
24.
WestSGEmlenWWenerMHKotzinBL. Neuropsychiatric lupus erythematosus: A 10-year prospective study on the value of diagnostic tests. Am J Med1995; 99: 153–163.
25.
WekkingEM. Psychiatric symptoms in systemic lupus erythematosus: An update. Psychosom Med1993; 55: 219–228.
26.
ArnettFCReveilleJDMoutsopoulosHMGeorgescuLElkonKB. Ribosomal P autoantibodies in systemic lupus erythematosus. Frequencies in different ethnic groups and clinical and immunogenetic associations. Arthritis Rheum1996; 39: 1833–1839.
27.
ShortallEIsenbergDNewmanSP. Factors associated with mood and mood disorders in SLE. Lupus1995; 4: 272–279.
28.
HanlyJGSuLFarewellVMcCurdyGFougereLThompsonK. Prospective study of neuropsychiatric events in systemic lupus erythematosus. J Rheumatol2009; 36: 1449–1459.
29.
JarpaEBabulMCalderonJet al.Common mental disorders and psychological distress in systemic lupus erythematosus are not associated with disease activity. Lupus2011; 20: 58–66.
30.
PostalMAppenzellerS. The importance of cytokines and autoantibodies in depression. Autoimmun Rev2015; 14: 30–35.
31.
KarolDECriscione-SchreiberLGLinMClowseME. Depressive symptoms and associated factors in systemic lupus erythematosus. Psychosomatics2013; 54: 443–450.
AinialaHLoukkolaJPeltolaJKorpelaMHietaharjuA. The prevalence of neuropsychiatric syndromes in systemic lupus erythematosus. Neurology2001; 57: 496–500.
34.
SannaGBertolacciniMLCuadradoMJet al.Neuropsychiatric manifestations in systemic lupus erythematosus: Prevalence and association with antiphospholipid antibodies. J Rheumatol2003; 30: 985–992.
35.
AndradeABBosiMLM. Qualidade do cuidado em dois centros de atenção psicossocial sob o olhar de usuários. Saúde Soc São Paulo2015; 24: 887–900.
36.
OriveMPadiernaJAQuintanaJMLas-HayasCVrotsouKAguirreU. Detecting depression in medically ill patients: Comparative accuracy of four screening questionnaires and physicians’ diagnoses in Spanish population. J Psychosom Res2010; 69: 399–406.
37.
HwangJLeeJAhnJKParkEJChaHSKohEM. Clinical characteristics of male and female Korean patients with systemic lupus erythematosus: A comparative study. Korean J Intern Med2015; 30: 242–249.
38.
AranowCDel GuidiceJBarlandPWeinsteinA. Systemic lupus erythematosus disease severity in men and women: A case-control study. J Rheumatol2002; 29: 1674–1677.
39.
LuLJWallaceDJIshimoriMLScofieldRHWeismanMH. Review: Male systemic lupus erythematosus: A review of sex disparities in this disease. Lupus2010; 19: 119–129.
40.
RenauAIIsenbergDA. Male versus female lupus: A comparison of ethnicity, clinical features, serology and outcome over a 30 year period. Lupus2012; 21: 1041–1048.
41.
SpeckerCBeckerALakomekHJBachDGrabenseeB. Systemic lupus erythematosus in men–a different prognosis?Z Rheumatol1994; 53: 339–45.
42.
TanTCFangHMagderLSPetriMA. Differences between male and female systemic lupus erythematosus in a multiethnic population. J Rheumatol2012; 39: 759–769.
43.
MacedoEAAppenzellerSCostallatLT. Gender differences in systemic lupus erythematosus concerning anxiety, depression and quality of life. Lupus2016; 25: 1315–1327.
44.
TanEMCohenASFriesJFet al.The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum1982; 25: 1271–1277.
45.
HochbergMC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum1997; 40: 1725–1725.
46.
AssociationAP. Diagnostic and statistical manual of mental disorders, 5th ed. Arlington: American Psychiatric Association, 2013.
47.
BeckATWardCHMendelsonMMockJErbaughJ. An inventory for measuring depression. Arch Gen Psychiatry1961; 4: 561–571.
48.
GorensteinCAndradeL. Validation of a Portuguese version of the Beck Depression Inventory and the State-Trait Anxiety Inventory in Brazilian subjects. Braz J Med Biol Res1996; 29: 453–457.
49.
RadloffLS. The CES-D Scale: A self-report depression scale for research in the general population. Appl Psychol Meas1977; 1: 385–401.
50.
Silveira DXJ, Jorge MR. Propriedades psicométricas da escala de rastreamento populacional para depressão CES-D em populações clínica e não-clínica de adolescentes e adultos jovens. Rev Psiq Clín 1998; 25: 251–261.
51.
ZigmondASSnaithRP. The hospital anxiety and depression scale. Acta Psychiatr Scand1983; 67: 361–370.
52.
Botega NJB, Bio MR, Zomignani MA, Garcia C Jr, Pereira WAB. Transtornos do humor em enfermaria de clínica médica e validação de escala de medida (HAD) de ansiedade e depressão. Rev Saúde Pública 1995; 29: 355–363.
53.
The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 1999; 42: 599–608.
54.
BeckATSteerARGarbinMG. Psychometric properties of the Beck Depression Inventory: Twenty-five years of evaluation. Clin Psychol Rev1988; 8: 77–100.
55.
Van ExelEJacobsJKorswagenLAet al.Depression in systemic lupus erythematosus, dependent on or independent of severity of disease. Lupus2013; 22: 1462–1469.
56.
LykourasELoannidisCVoulgariAJemosJTzonouA. Depression among general hospital patients in Greece. Acta Psychiatr Scand1989; 79: 148–152.
57.
HengeveldMWAncionFARooijmansHG. Prevalence and recognition of depressive disorders in general medical inpatients. Int J Psychiatry Med1987; 17: 341–349.
58.
JuddFKMijchAM. Depression in patients with HIV and AIDS. Aust N Z L Psychiatry1994; 28: 642–650.
59.
Brazilian Association of Research Companies. 2014 economic classification criteria Brazil, http://www.abep.org/criterio-brasil (2014, accessed 25 December 2015).
60.
BombardierCGladmanDDUrowitzMBCaronDChangCH. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum1992; 35: 630–640.
61.
GladmanDGinzlerEGoldsmithCet al.The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum1996; 39: 363–369.
62.
FleissJL. Statistical methods for rates and proportions, 2nd ed. New York: John Wiley & Sons Inc., 1981.
63.
LandisJRKochGG. The measurement of observer agreement for categorical data. Biometrics1977; 33: 159–174.
64.
SAS System for Windows. 9.4 ed.: Statistical Analysis System Institute Inc., Cary, USA.
65.
NanthakumarSBucksRSSkinnerTC. Are we overestimating the prevalence of depression in chronic illness using questionnaires? Meta-analytic evidence in obstructive sleep apnoea. Health Psychol2016; 35: 423–432.
66.
ToupsMCarmodyTTrivediMHRushAJHedayatiSS. Performance of depression rating scales in patients with chronic kidney disease: An item response theory-based analysis. Gen Hosp Psychiatry2016; 42: 60–66.
67.
MoullecGPlourdeALavoieKLSuarthanaEBaconSL. Beck Depression Inventory II: Determination and comparison of its diagnostic accuracy in cardiac outpatients. Eur J Prev Cardiol2015; 22: 665–672.
68.
EnglbrechtMAltenRAringerMet al.Validation of standardized questionnaires evaluating symptoms of depression in rheumatoid arthritis patients – approaches to screening for a frequent and yet underrated challenge. Arthritis Care Res2016; 69: 58–66.
69.
FischerAFischerMNichollsRAet al.Diagnostic accuracy for major depression in multiple sclerosis using self-report questionnaires. Brain Behav2015; 5: e00365–e00365.
70.
SheanGBaldwinG. Sensitivity and specificity of depression questionnaires in a college-age sample. J Genet Psychol2008; 169: 281–288.
71.
StrikJJHonigALousbergRDenolletJ. Sensitivity and specificity of observer and self-report questionnaires in major and minor depression following myocardial infarction. Psychosomatics2001; 42: 423–428.
72.
JulianLJGregorichSETonnerCet al.Using the Center for Epidemiologic Studies Depression Scale to screen for depression in systemic lupus erythematosus. Arthritis Care Res2011; 63: 884–890.
73.
TerluinBBrouwersEPvan MarwijkHWVerhaakPvan der HorstHE. Detecting depressive and anxiety disorders in distressed patients in primary care; comparative diagnostic accuracy of the Four-Dimensional Symptom Questionnaire (4DSQ) and the Hospital Anxiety and Depression Scale (HADS). BMC Fam Pract2009; 10: 58–58.
74.
BocereanCDupretE. A validation study of the Hospital Anxiety and Depression Scale (HADS) in a large sample of French employees. BMC Psychiatry2014; 14: 354–354.
75.
VallejoMARiveraJEsteve-VivesJRodriguez-MunozMFGrupoI. Use of the Hospital Anxiety and Depression Scale (HADS) to evaluate anxiety and depression in fibromyalgia patients. Revista de psiquiatria y salud mental2012; 5: 107–114.
76.
CovicTCummingSRPallantJFet al.Depression and anxiety in patients with rheumatoid arthritis: Prevalence rates based on a comparison of the Depression, Anxiety and Stress Scale (DASS) and the hospital, Anxiety and Depression Scale (HADS). BMC Psychiatry2012; 12: 6–6.
77.
SmarrKLKeeferAL. Measures of depression and depressive symptoms: Beck Depression Inventory-II (BDI-II), Center for Epidemiologic Studies Depression Scale (CES-D), Geriatric Depression Scale (GDS), Hospital Anxiety and Depression Scale (HADS), and Patient Health Questionnaire-9 (PHQ-9). Arthritis Care Res2011; 63(Suppl. 11): S454–S466.
78.
SantosISTavaresBFMunhozTNet al.Patient Health Questionnaire-9 versus Edinburgh Postnatal Depression Scale in screening for major depressive episodes: A cross-sectional population-based study. BMC Res Notes2017; 10: 57–57.
79.
SharpR. The Hamilton Rating Scale for Depression. Occup Med2015; 65: 340–340.
80.
BondolfiGJermannFRougetBWet al.Self- and clinician-rated Montgomery–Asberg Depression Rating Scale: Evaluation in clinical practice. J Affect Disord2010; 121: 268–272.
81.
WilliamsJWJrPignoneMRamirezGPerez StellatoC. Identifying depression in primary care: A literature synthesis of case-finding instruments. Gen Hosp Psychiatry2002; 24: 225–237.
82.
BoydJHWeissmanMMThompsonWDMyersJK. Screening for depression in a community sample. Understanding the discrepancies between depression symptom and diagnostic scales. Arch Gen Psychiatry1982; 39: 1195–1200.
83.
MulrowCDWilliamsJWJrGeretyMBRamirezGMontielOMKerberC. Case-finding instruments for depression in primary care settings. Ann Intern Med1995; 122: 913–921.
84.
GeretyMBWilliamsJWJrMulrowCDet al.Performance of case-finding tools for depression in the nursing home: Influence of clinical and functional characteristics and selection of optimal threshold scores. J Am Geriatr Soc1994; 42: 1103–1109.
85.
KesslerRC. Epidemiology of women and depression. J Affect Disord2003; 74: 5–13.
86.
MarcusSMYoungEAKerberKBet al.Gender differences in depression: Findings from the STAR*D study. J Affect Disord2005; 87: 141–150.
87.
SloanDMKornsteinSG. Gender differences in depression and response to antidepressant treatment. Psychiatr Clin N Am2003; 26: 581–594.
88.
SloanDMSandtAR. Gender differences in depression. Women Health2006; 2: 425–434.
